USD 0.23
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.46 Million USD | -86.17% |
2022 | 10.61 Million USD | -71.21% |
2021 | 36.86 Million USD | -22.47% |
2020 | 47.54 Million USD | 41.21% |
2019 | 33.66 Million USD | 350.56% |
2018 | 7.47 Million USD | 373500.0% |
2017 | 2000.00 USD | -93.55% |
2016 | 31 Thousand USD | -99.17% |
2015 | 3.72 Million USD | 16108.7% |
2014 | 23 Thousand USD | -11.54% |
2013 | 26 Thousand USD | 44.44% |
2012 | 18 Thousand USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 5.82 Million USD | 12033.33% |
2009 | 48 Thousand USD | -98.07% |
2008 | 2.48 Million USD | 4.06% |
2007 | 2.38 Million USD | 1204.92% |
2006 | 183 Thousand USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 6.67 Million USD | 312.62% |
2024 Q1 | 1.61 Million USD | 10.22% |
2023 Q3 | 14.24 Million USD | 17.61% |
2023 Q2 | 12.1 Million USD | 20.93% |
2023 Q1 | 10.01 Million USD | -5.64% |
2023 FY | 1.46 Million USD | -86.17% |
2023 Q4 | 1.46 Million USD | -89.7% |
2022 Q4 | 10.61 Million USD | 6.78% |
2022 Q3 | 9.93 Million USD | 40.47% |
2022 Q2 | 7.07 Million USD | -58.78% |
2022 Q1 | 17.16 Million USD | -53.45% |
2022 FY | 10.61 Million USD | -71.21% |
2021 Q3 | 47.62 Million USD | 0.03% |
2021 Q2 | 47.61 Million USD | -0.01% |
2021 Q1 | 47.61 Million USD | 0.16% |
2021 FY | 36.86 Million USD | -22.47% |
2021 Q4 | 36.86 Million USD | -22.61% |
2020 Q4 | 47.54 Million USD | 0.08% |
2020 FY | 47.54 Million USD | 41.21% |
2020 Q1 | 35.18 Million USD | 4.5% |
2020 Q2 | 36.83 Million USD | 4.69% |
2020 Q3 | 47.5 Million USD | 28.97% |
2019 Q1 | 8.86 Million USD | 18.59% |
2019 Q4 | 33.66 Million USD | 5.25% |
2019 Q3 | 31.98 Million USD | 107.74% |
2019 FY | 33.66 Million USD | 350.56% |
2019 Q2 | 15.39 Million USD | 73.77% |
2018 FY | 7.47 Million USD | 373500.0% |
2018 Q1 | - USD | -100.0% |
2018 Q2 | 4.86 Million USD | 0.0% |
2018 Q3 | 7.41 Million USD | 52.42% |
2018 Q4 | 7.47 Million USD | 0.77% |
2017 Q2 | 14 Thousand USD | -36.36% |
2017 FY | 2000.00 USD | -93.55% |
2017 Q1 | 22 Thousand USD | -29.03% |
2017 Q4 | 2000.00 USD | -66.67% |
2017 Q3 | 6000.00 USD | -57.14% |
2016 Q3 | 40 Thousand USD | -28.57% |
2016 Q2 | 56 Thousand USD | 47.37% |
2016 FY | 31 Thousand USD | -99.17% |
2016 Q1 | 38 Thousand USD | -98.98% |
2016 Q4 | 31 Thousand USD | -22.5% |
2015 FY | 3.72 Million USD | 16108.7% |
2015 Q4 | 3.72 Million USD | 21829.41% |
2015 Q3 | 17 Thousand USD | 30.77% |
2015 Q2 | 13 Thousand USD | -27.78% |
2015 Q1 | 18 Thousand USD | -21.74% |
2014 Q3 | 23 Thousand USD | 15.0% |
2014 Q4 | 23 Thousand USD | 0.0% |
2014 FY | 23 Thousand USD | -11.54% |
2014 Q1 | 24 Thousand USD | -7.69% |
2014 Q2 | 20 Thousand USD | -16.67% |
2013 Q3 | 18 Thousand USD | -10.0% |
2013 Q2 | 20 Thousand USD | 33.33% |
2013 Q1 | 15 Thousand USD | -16.67% |
2013 FY | 26 Thousand USD | 44.44% |
2013 Q4 | 26 Thousand USD | 44.44% |
2012 Q1 | - USD | 0.0% |
2012 FY | 18 Thousand USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | 21 Thousand USD | 0.0% |
2012 Q4 | 18 Thousand USD | -14.29% |
2011 Q1 | 2000.00 USD | -99.97% |
2011 FY | - USD | -100.0% |
2011 Q2 | - USD | -100.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q3 | 7000.00 USD | -69.57% |
2010 Q2 | 23 Thousand USD | -39.47% |
2010 Q4 | 5.82 Million USD | 83100.0% |
2010 FY | 5.82 Million USD | 12033.33% |
2010 Q1 | 38 Thousand USD | -20.83% |
2009 Q2 | 63 Thousand USD | -11.27% |
2009 Q1 | 71 Thousand USD | -97.14% |
2009 Q4 | 48 Thousand USD | -5.88% |
2009 Q3 | 51 Thousand USD | -19.05% |
2009 FY | 48 Thousand USD | -98.07% |
2008 Q3 | 2.5 Million USD | 7.38% |
2008 Q4 | 2.48 Million USD | -0.72% |
2008 Q1 | 2.35 Million USD | -1.51% |
2008 FY | 2.48 Million USD | 4.06% |
2008 Q2 | 2.33 Million USD | -0.89% |
2007 Q1 | 11.19 Million USD | 6015.3% |
2007 Q3 | 11.65 Million USD | 2.07% |
2007 Q2 | 11.42 Million USD | 2.06% |
2007 FY | 2.38 Million USD | 1204.92% |
2007 Q4 | 2.38 Million USD | -79.52% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q4 | 183 Thousand USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | 183 Thousand USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
CareCloud, Inc. | 10.03 Million USD | 85.384% |
Augmedix, Inc. | 15.3 Million USD | 90.414% |
BrightSpring Health Services, Inc. Common Stock | 3.33 Billion USD | 99.956% |
CareCloud, Inc. | 10.03 Million USD | 85.384% |
HealthEquity, Inc. | 874.97 Million USD | 99.832% |
iCoreConnect Inc. | 1.42 Million USD | -3.3% |
Inovalon Holdings, Inc. | 877.57 Million USD | 99.833% |
Nutex Health, Inc. | 26.31 Million USD | 94.425% |
Omnicell, Inc. | 569.66 Million USD | 99.742% |
OneMedNet Corporation | 465.02 Thousand USD | -215.468% |
Progyny, Inc. | 17.24 Million USD | 91.491% |
Renalytix Plc | 4.33 Million USD | 66.128% |
Schrödinger, Inc. | 111.01 Million USD | 98.679% |
Simulations Plus, Inc. | 531 Thousand USD | -176.271% |
SOPHiA GENETICS SA | 15.67 Million USD | 90.64% |
Streamline Health Solutions, Inc. | 9.06 Million USD | 83.819% |
GE HealthCare Technologies Inc. | 8.74 Billion USD | 99.983% |
Sharecare, Inc. | 519 Thousand USD | -182.659% |
Aclarion, Inc. | - USD | -Infinity% |
CareMax, Inc. | 21.44 Million USD | 93.159% |
Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
Forian Inc. | 22.99 Million USD | 93.619% |
Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
HeartBeam, Inc. | - USD | -Infinity% |
GeneDx Holdings Corp. | 52.68 Million USD | 97.216% |
SCWorx Corp. | 90.35 Thousand USD | -1523.524% |
Minerva Surgical, Inc. | 37.44 Million USD | 96.082% |
Definitive Healthcare Corp. | 242.56 Million USD | 99.395% |
10x Genomics, Inc. | 83.84 Million USD | 98.25% |
Zhongchao Inc. | 571.86 Thousand USD | -156.53% |
Accolade, Inc. | 208.48 Million USD | 99.296% |
MSP Recovery, Inc. | 678.98 Million USD | 99.784% |
R1 RCM Inc. | 1.64 Billion USD | 99.911% |
Spok Holdings, Inc. | 6.9 Million USD | 78.745% |
Privia Health Group, Inc. | 5.24 Million USD | 72.036% |
EUDA Health Holdings Limited | 75.11 Thousand USD | -1853.109% |
TruBridge, Inc. | 198.34 Million USD | 99.26% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 3.33 Billion USD | 99.956% |
Sharecare, Inc. | 519 Thousand USD | -182.659% |
Health Catalyst, Inc. | 228.03 Million USD | 99.357% |
GoodRx Holdings, Inc. | 647.7 Million USD | 99.774% |
Premier, Inc. | 11.17 Million USD | 86.867% |
HealthStream, Inc. | 20.24 Million USD | 92.754% |
Certara, Inc. | 288.21 Million USD | 99.491% |
GeneDx Holdings Corp. | 52.68 Million USD | 97.216% |
Ontrak, Inc. | 1.46 Million USD | 0.0% |
SHL Telemedicine Ltd. | 10.43 Million USD | 85.94% |
CareCloud, Inc. | 10.03 Million USD | 85.384% |
EUDA Health Holdings Limited | 75.11 Thousand USD | -1853.109% |
HeartBeam, Inc. | - USD | -Infinity% |
Mangoceuticals, Inc. | 64.96 Thousand USD | -2158.278% |
CareMax, Inc. | 21.44 Million USD | 93.159% |
Healthcare Triangle, Inc. | 888 Thousand USD | -65.203% |
National Research Corporation | 29.47 Million USD | 95.022% |
Aclarion, Inc. | - USD | -Infinity% |
OptimizeRx Corporation | 34.23 Million USD | 95.714% |